HD-OPM Archive
Topics › Statins

STREAM: why 'noninferior' does not make stopping statins at age 70 safe

Louis Nervegna · Nov 15, 2026 · ♥ 4 reactions · 11 comments · original Facebook post
StatinsGuidelines, policy & public healthAging & longevity
AI summary & key facts

Louis shares a cardiologist's video commentary on the STREAM randomized trial of stopping statins after age 70. The commentary stresses that the stop group had roughly 38% more events in relative terms (12.7% vs 9.2%), that noninferiority only means the difference fell within a preset margin, and that the safety board advised discussing restarting. Stopping can be appropriate based on frailty or side effects, but not simply because of age.

He is commenting on the recent STREAM randomized trial, which tested whether or not it was safe for patients older than 70yo to stop taking statins.

Quoted from the original post:

Stopping statins after 70 is SAFE? I’m not buying that conclusion so easily.

A new study presented at AHA 2026 and published in the New England Journal of Medicine asked a simple question: Can older adults safely stop taking their statins?

The STREAM trial randomized 1,880 adults aged 70 and older, all without known cardiovascular disease, to continue or discontinue their statins.

Here’s what happened:

🔴 Stopped statins: 12.7% experienced a heart attack, ischemic stroke, or death.

🟢 Continued statins: 9.2% experienced those outcomes.

That’s approximately 38% more events in relative terms among those assigned to stop their statins.

Yet the study concluded that stopping was noninferior.

How? Because the trial was designed with a predefined margin of acceptable difference. And statistically, it met that margin.

But here’s what bothers me.

There was no meaningful improvement in muscle pain, quality of life, falls, or sarcopenia.

And the independent data and safety monitoring board ultimately recommended that patients assigned to stop statins discuss restarting them with their doctors.

Noninferiority does not mean the two strategies produced identical outcomes.

Can stopping statins be appropriate? Absolutely. Frailty, life expectancy, adverse effects, and individual cardiovascular risk matter.

But stopping simply because someone turned 70? I wouldn’t recommend that.

Now I want your opinion: If a study showed more heart attacks, strokes, and deaths after stopping a medication, would you consider stopping it?

Reference: Rodondi et al. STREAM. NEJM. November 2026. DOI: 10.1056/NEJMoa2606634.

#streamHD #statinsHD #elderlyHD #statinselderlyHD

Research cited

← newer: Stopping statins after 70 raised events from 9.2% to 12.7% iolder: COSMOS multivitamin matches Centrum-type RDA doses except B1 →